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1. INTRODUCTION 
The objective of this report is to present to the Council and the European Parliament, in 
accordance with Article 26 of Directive 86/609/EEC of 24 November 1986 on the 
approximation of laws, regulations and administrative provisions of the Member States 
regarding the protection of animals used for experimental and other scientific purposes1, the 
statistical data on the number of animals used for experimental and other scientific purposes 
in the Member States of the EU. 
The first two statistical reports published in 19942 and 19993 covering data on experimental 
animals collected in 1991 and 1996 respectively provided a limited amount of statistical 
analysis due to the absence of a consistent system of reporting the data on the use of 
experimental animals in the Member States. In 1997 an agreement was reached between the 
competent authorities of the Member States and the Commission to submit data for the future 
reports under a format of eight harmonized tables. The third and the fourth statistical reports 
                                                 
1 OJ L 358, 18.12.1986, p.1. 
2 COM (94) 195 final 
3 COM (1999) 191 final 
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published in 20034 and 20055 covering data collected in 1999 and 2002 were based on these 
agreed harmonized tables. This allowed a much wider interpretation of the results on the use 
of experimental animals in the EU. In spite of the progress made in the content of these two 
last statistical reports, it ought to be stressed that there were some inconsistencies in the data 
submitted by the Member States. 
This Fifth Statistical Report covers for the first time data collected by 25 Member States as a 
result of the accession of 10 new Member States in 2004. It gives an overview of the year 
2005 with the exception of one Member State who reported data of 2004.  
This Report summarizes the data and conclusions found in the Commission Staff Working 
Document - "Fifth Report on the Statistics on the Number of Animals used for Experimental 
and other Scientific Purposes in the Member States of the European Union". 
I. DATA SUBMITTED AND GENERAL ASSESSMENT 
I.1. Data submitted by the Member States  
All Member States submitted the data for 2005 in the agreed EU format. Regarding the 
quality of data, Member States have applied a quality control check on their respective set of 
data. This exercise was the first for the 10 new Member States (EU 10), and in general the 
coherence of the data has greatly improved for the other Member States. 
For the present report it was generally considered that the quality criteria had sufficiently been 
respected to allow an analysis at European level of all eight EU tables for the first time. 
The individual data from the Member States together with their respective comments and 
interpretations can be found in the Staff Working Document. 
I.2. General assessment 
The EU 10 are reporting data for the first time, therefore it is not possible to draw conclusions 
on the evolution of the use of animals for experimental purposes in the EU by comparing data 
with those of the previous reports. However, some comparisons in trends will be attempted 
and significant changes in use will be highlighted in the report. Malta informed the 
Commission that no animal experiments were carried out in their country in 2005. 
The total number of animals used for experimental and other scientific purposes in 2005 in the 
25 Member States (EU 25) amounts to 12,1 million (with data from France of 2004). The 
number of animals used in the EU 10 represents 8,6% of the total number of animals used in 
the EU 25. 
As in previous reports rodents together with rabbits represent almost 78% of the total number 
of animals used in the EU. Mice are by far the most commonly used species covering 53% of 
the total use, followed by rats with 19%. 
The second most used group of animals was, as in previous years, cold-blooded animals 
representing 15%. The third biggest group of animals was birds with a little over 5% of the 
total use. 
As in 2002, no Great Apes were used in experiments in the EU in 2005. 
                                                 
4 COM (2003) 19 final 
5 COM (2005) 7 final 
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II. RESULTS 
III.1. Results of EU Table 1: Species and number of animals 
The total number of animals used in 2005 in the EU 25 amounts to 12,1 million animals. Mice 
(53%) and rats (19%) were by far the most used species (fig.1.1). Rodents together with 
rabbits represent 77,5% of the total number of animals used. Cold-blooded animals with 15% 
represented the second most used group of animals followed by birds with 5,4%. The Artio 
and Perissodactyla group including horses, donkeys and crossbreeds (Perrisodactyla), pigs, 
goats, sheep and cattle (Artiodactyla) represented only 1,1%. Carnivores represented 0,3% of 
the total number of animals used in 2005 and non-human primates represent 0,1%. 
Figure 1.1
Percentages of animals used by classes by the reporting 
Member States 
Mice 53%
Rats 19%
Guinea-Pigs 2,1%
Other rodents 0,8%
 Rabbits 2,6%
Cold-blooded  animals 
15%
 Birds 5,4%
Artio+perissodactyla 
1,1%
 Carnivores 0,33% Prosimians+Monkeys+
Apes 0,09%
Other mammals 0,08%
 
III.1.1. Comparison with the data of the previous reports  
The number of animals used in the EU 10, which reported for the first time, represents 8,6% 
of the total number of animals in the EU 25. This proportion will be used as the basis to 
highlight any changes in trends which significantly deviate from it. 
Comparison between proportions of classes of animals used in 1996, 1999 
2002 and 2005 
Class of species 1996(*) 1999 2002(**) 2005(***) 
% Rodents-rabbits 81,3 86,9 78,0 77,5 
% Cold-blooded animals 12,9 6,6 15,4 15, 
% Birds  4,7 5 5,4 
% Artio Perissodactyla  1,2 1,2 1,1 
(*) 14 Member States reporting for 1996, one for 1997 
(**) 14 Member States reporting for 2002, one for 2001 
(***) 25 Member States reporting for 2005, one for 2004 
From the above table, overall, the percentages of rodents and rabbits show some fluctuation 
around 80%. For cold-blooded animals the proportion used in 1996, in 2002 and 2005 is 
between 10 to 15% but a much lower use of 6,6% was observed in 1999. Birds representing 
the third largest percentage of animal used, varies between 4 to 5%. The group of artio and 
perissodactyla fluctuates around 1%. 
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The inclusion of the data of the EU 10 should in principle increase the actual numbers of 
animals of each species with the magnitude of around 8,6%. However, the use of some 
species has decreased compared to the 2002 report. The total number of hamsters, goats, 
prosimians, quails and reptiles have all decreased from 40% to 22%.  
The biggest percentual change has, however, been noted in the increase of the use of 'other 
carnivores', although these species are not used in great numbers (from 3110 to 8711). This is 
further contrasted against a decrease in their use in the EU 15. The other large increase both in 
the EU 25 and also in the EU 15 is for the use of 'other mammals' (from 3618 to 9950). 
One new Member State reported significant use of 'other carnivores', 'other mammals', cattle, 
'other rodents', quails and horses, pigs and other birds, in comparison with other Member 
States. This was attributed to wildlife and environmental research studies in that specific 
geographical location, and testing in the areas of agricultural and animal breeding specific to 
that Member State. For further details see the Staff Working Document, section B. 
Among the other significant increases in the species used in greater numbers, one should 
mention the increase in the use of ferrets (29%), of cattle (36%), of 'other birds' (25%) and of 
amphibians (25%). These increases apart from ferrets are all to be attributed to some of the 
new Member States. 
The use of non-human primates remained as in previous reports at around 0,1% of the total 
number of animals used. However, by looking at the species, the number of prosimians used 
decreased by 38% while new world monkeys increased by 31%. 
Member States reported that these changes may be attributed to changes in regulatory 
requirements for pharmaceuticals and in toxicological safety testing.  
III.1.2. Comparison with the data of the previous reports for the EU 15 
Since the total number of animals include the data from the 10 new Member States it is not 
possible to draw comparison per se with the results of the previous reports. However, to allow 
for some comparisons of trends of the animal use, a comparison of the number of animals 
used by the EU 15 in 2002 and by the EU 15 in 2005 was made. 
In EU 15, the total number of animals used increased in 2005 by 339,279 which represents an 
increase of 3,1% with regard to 2002. 
By examining the data by species, the major increase observed in 2005 is the additional use of 
about 579,000 mice (10,6%). However this increase of mice is partly compensated by a 
decrease of the number of rats, hamsters and other rodents used (36%). In 2005 there is also 
an increase of the number of rabbits used for experimental purposes (9,5%). 
Among the other classes of animals, the use of ferrets for carnivores (20,8%) and the use of 
'other mammals' (30%) has increased. The changes in the use of non-human primates are 
mostly results of changes in EU 15 as only 57 old world monkeys were used in EU 10 in 
2005. 
On the other hand, the use of all species, within the class of artio and perisodactyla have 
decreased in comparison to 2002. The same is observed with birds. Finally, one can observe a 
substantial decrease of 73% in the use of reptiles. 
Further breaking down the category 'other', Member States reported use of the following 
species: 
Other rodents: gerbils, old world jerboas; chinchilla, beaver, ground squirrel, hamsters, 
aremenio (Cricetulus migratorius) and different species of mice; 
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Other carnivores: wild-life species used for zoological and ecological studies (e.g. foxes, badgers, 
seals), otters, fitchew; 
Other mammals: boars, bats and shrews, llama, mole, European bison and red deer; 
Other birds: mainly coturnix japonica and bob-white quail, poultry species, and zebra finches, 
canary, parakeet, parrot and farmed avian species for example, Gallus gallus domesticus. 
III.2. Further results of EU Table 1: Origin of animals used 
Although the origin only has to be reported for selected animal species, it is evident that the 
majority of the species originated mainly from EU countries (fig 1.2), with the exception of 
old world monkeys. 
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Figure 1.2:  Origin of species 
Other countries
ETS 123 countries
EU countries
 
The general pattern on the origin of the species is quite similar to that observed in the 
previous reports. It should be noted however, that for the first time in 2005 the prosimians 
were all of EU origin. A similar trend can also be observed with the new world monkeys 
where an increasing amount was either of EU or ETS 123 origin at the expense of other 
countries. Also, old world monkeys coming from EU origins increased. On the other hand the 
number of cats not of European origin has increased in comparison to the report of 2002. 
III.3. Results of EU Table 2: Purposes of the experiments 
More than 60% of animals were used in research and development for human medicine, 
veterinary medicine, dentistry and in fundamental biology studies (fig 2.1). Production and 
quality control of products and devices in human medicine, veterinary medicine and dentistry 
required the use of 15,3% of the total number of animals reported in 2005. Toxicological and 
other safety evaluation represented 8% of the total number of animals used for experimental 
purposes. 
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Figure 2.1 
Purposes of experiments
Research and develop 
human +veterin+dentist 
31%
Fundamental biology 
studies 33%
Diagnosis of disease 2%
Other 8%
Education and training 
1,6%
Production and quality 
control human medicine 
and dentistry  11,8%
Production and quality 
control veterinary 
medicine 3.5%
Toxicological and other 
safety evaluation 8%
 
Comparison with the data of the previous report  
The comparison is aiming to detect changes in trends rather than drawing formal conclusions. 
The most significant change that can be identified is the number of animals used for 
toxicological and other safety evaluation, which has dropped from about 9,9% (data of 2002) 
to 8%. The decrease is also important in total numbers, i.e. from 1,066,047 to 1,026,286 
animals while at the same time covering the 10 new Member States. 
The percentage of animals used for education and training is also showing a decreasing trend, 
while 'other' purposes seem to indicate an increase. In terms of numbers of animals the 
decrease ranges from 341,967 to 198,994 and the increase from 597,960 to 984,238 
respectively. The decrease of animals used for education and training can be attributed to both 
an uptake of alternative techniques and the re-use of animals. 
'Other' purposes covers amongst other things virology, immunology for production of 
monoclonal and polyclonal antibodies, physiology of foetal-maternal interaction in mouse 
gene transgensis, oncological treatment, pharmaceutical R&D, combined drug testing and 
genetics. 
III.4. Results of EU Table 3: Toxicological and safety evaluation by type of 
product/endpoints 
Only 8% of the total number of animals used for experimental purposes is used for 
toxicological and other safety evaluation. Products or devices used for human medicine, 
veterinary medicine and dentistry represents 50,9% (fig 3.1) of the animals used for 
toxicological or other safety evaluations. The percentage of animals used for toxicological 
evaluation of groups of products/substances, i.e., animal feed, additives for human food 
consumption, cosmetics and household, is very small (4,3%) when compared to the other 
products groups. 
The group of products/substances falling under the scrutiny of authorities concerned with 
safety of health and of the environment by chemical products, such as industrial chemicals 
and pesticides, used 19% of the animals for toxicological and other safety evaluations. 
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Figure 3.1
Animals used in toxicological and other safety experiments
3.3     Products/ substances 
used or intended to be used 
mainly in agriculture
9,5%
3.5   Products/ substances 
used or intended to be used 
mainly in the household
0,1%
3.4   Products/ substances 
used or intended to be used 
mainly in industry
9,4%
3.6    Products/ substances 
used or intended to be used 
mainly as cosmetics or  
toiletries
0,5%
3.7    Products/ substances 
used or intended to be used 
mainly as additives in food for 
human consumption
0,4%
3.8    Products/ substances 
used or intended to be used 
mainly as additives in food for 
animal consumption
3,3%
3.9   Potential  or actual 
contaminents in the general 
environment which do not 
appear in other columns
8,3%
3.2    Products/ substances 
or devices for human 
medicine and dentistry and 
for veterinary medicine
50,9%
3.10    Other  toxicological or 
safety evaluations
17,6%
 
There is a strong decrease in the number of animals used for toxicological tests for products 
intended for industry, for agriculture, products for potential contaminants of the environment 
(decrease ranging from above 123,000 to below 98,000) and also tests for products for 
household and for additives in food for human consumption, categories using lower numbers, 
in comparison to the data submitted in the last statistical report. 
There is however a noticeable increase in the number of animals used for cosmetics or 
toiletries (50%), however, the actual numbers of animals in this category remain low (5,571 in 
total). This increase, attributed mainly to one old Member State, is worth noting in light of the 
legal requirement to phase out animal testing for cosmetics in the EU. There is also a 
significant increase in the number of animals used for tests for additives in food for animal 
consumption (3,447 to 34,225 - 10 fold). 
It should be noted that in comparison to 2002 there is a significant increase in the number of 
animals used for 'other' toxicological or safety evaluation (ranging from around 110,000 to 
180,000). Member States reported that it concerned new methods and tests, such as: tests on 
transmission of microcystins on embryonic membrane; bioassays; toxicity evaluation for 
humans via the environment; and control of safety for toys. 
III.5. Results of EU Table 4: Animals used for studies of diseases 
In 2005, the number of animals used for the study of both animal and human diseases 
represented more than half (57,5%) the total number of animals used for experimental 
purposes in the EU. The percentage of the number of animals used for studies of human 
diseases represents 81% of the total number of animals used for all studies of diseases (fig 
4.1). 
 EN 9   EN 
Figure 4.1
Proportion of animals used for the study of diseases
Human 
Cardiovascular 
diseases
6%
Human cancer (excl. 
evaluation of carcino 
hazards)
12,8%
Human nervous and 
mental disorder
21,6%
Other human 
diseases
40,5%
Specific animal 
diseases
19%
 
In 2005, the proportion and the number of animals used (ranging from 900,000 to 1,329,000) 
for the studies of animal diseases have increased significantly when compared with the report 
of 2002. 
Studies on specific animal diseases are important in the light of epidemics of farm animals 
such as in the case of cows, foot and mouth disease, swine fever and more recently avian 
flew. Animals used cover also study on genetic diseases. 
An important part, around 60%, of the increase of the total use of mice (579,000) in 
comparison with 2002, can be attributed to different studies of diseases. 
The relative percentage of animals per classes of species used in studies by type of diseases is 
presented in fig 4.2. The top of each bar shows the percentage of animals used for studies on 
specific animal diseases. Two groups of animals i.e. birds and cold-blooded animals account 
for more than 80% of such studies. It was reported that a significant number of vaccines are 
tested on these groups of animals. 
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Figure 4.2
Proportion of animals used by classes per type of studies of 
diseases
Specific animals diseases  %
Other human diseases %
Human cancer (excl. evaluation of
carcino hazards) %
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%
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III.6. Results of EU Table 5: Animals used in production and quality control of products 
for human medicine and dentistry and for veterinary medicine  
The number of animals used in tests for the production and quality control of products for 
human medicine and dentistry and for veterinary medicine represents 15,3% of the total 
number of animals used for experimental purposes. The largest proportion of animals in this 
area (57%) was used to simultaneously satisfy requirements from several legislations such as 
national, Community, Council of Europe or others (fig 5.1). The testing carried out to satisfy 
the EU legislation including the European Pharmacopoeia covered 33,3% of the animals used 
in this area. 
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Figure 5.1
Percentages of animals used for regulatory requirements for the  production and 
quality control of products and devices for human medicine, dentistry and for 
veterinary medicine
2,56
33,31
0,01
2,10
5,16
56,85
0,00 10,00 20,00 30,00 40,00 50,00 60,00
5.2     National legislation
specific to a single EC Member
State
5.3     EC legislation including
European Pharmacopoeia
(requirements)
5.4     Member Country of
Council of Europe (but not EC)
legislation
5.5    Other legislation
5.6      Any combination of 5.2/
5.3/ 5.4/ 5.5
 5.7       No regulatory
requirements
2005
 
The increase of the percentage, from 43,1% to 56,8%, of the number of animals used due to 
requirements laid down simultaneously by several pieces of legislation in comparison to 2002, 
is clearly showing a positive trend. This is likely to reflect an increased harmonisation of 
different legislative requirements. 
Another positive trend is the reduction of the number of animals, from 352,000 to 95,739, 
used for 'no regulatory requirements'. 
III.7. Results of EU harmonized Table 6: Origin of regulatory requirements for animals 
used in toxicological and other safety evaluations 
As pointed out earlier, the number of animals used in toxicological or other safety evaluation 
represents 8% of the total number of animals used for experimental purposes in the EU. 
Animals used to simultaneously satisfy regulatory requirements from several legislations 
covered more than half of the animals used in this area (54,2%) (fig 6.1). The testing required 
under the EU legislation including the European Pharmacopoeia accounts for the second 
highest percentage in this area, namely 23%. 
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Figure 6.1  
Percentages of animals used for regulatory requirements for toxicological 
and other safety evaluation  
23,65
0,12
3,93
54,20
9,39
8,71
0,00 10,00 20,00 30,00 40,00 50,00 60,00
6.2     National legislation
specific to a single EC Member
State
6.3     EC legislation including
European Pharmacopoeia
(requirements)
6.4     Member Country of
Council of Europe (but not EC)
legislation
6.5    Other legislation
6.6      Any combination of 6.2/
6.3/ 6.4/ 6.5
 6.7       No regulatory
requirements
 
It should be underlined that the proportional decrease of the numbers of animals used for 
toxicological and other safety evaluations since the last report, from 10% to 8%, represents at 
the same time a decrease of about 40,000 animals. The number of animals used for 'no 
regulatory requirements' decreased since the last report from 114,000 to 90,000 animals, a 
drop of 24,000 animals. 
Member States who were asked to provide some further explanation as to the reasons for this 
clear decrease of animals used for 'no regulatory requirements' compared to previous reports, 
indicated that the decrease was partially attributed to use of alternative in vitro methods and 
invertebrate animals. For example, safety pharmacological tests such as those used for 
supplementary batch control by the European Pharmacopoeia. In order to understand what is 
meant by the term 'no regulatory requirements', for example some Member States indicated 
that legal obligations to ensure quality and safety of imported drugs would be reported under 
this category. 
The testing to satisfy national legislation specific to a single Member State showed a decrease 
in this report with respect to the previous one but it represents about 15,500 animals i.e. 1,5% 
of the total number used for toxicological and other safety evaluations. 
III.8. Results of EU Table 7: Animals used in toxicity test for toxicological and other 
safety evaluations 
It can be seen in Figure 7.1 that the largest percentage of use of animals for toxicological and 
other safety evaluations is due to acute and sub-acute toxicity tests, 42% in 2005. Also taking 
into account sub-chronic and chronic toxicity, the percentage of animals used in short and 
long term systemic toxicity testing accounts for 53% of the experimental animals used in this 
area.  
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About 17,5% of animals were used for testing carcinogenicity, mutagenicity and toxicity to 
reproduction in 2005. Another important category of use of animals in 2005 is for 'other tests' 
with 22,3%. Breaking down further the category 'other', Member States reported testing in 
areas such as biological screening for pharmaceutical, healthcare and veterinary products. 
This includes neurotoxicity, toxicokinetics, testing of acute dermal toxicity, testing of 
biological evaluation of medical devices: Intracutan testing of reactivity on rabbits, study into 
penetration of nanoparticle through tissue and their biocompatibility, study into evaluation of 
sensitization potential of dyestuffs used in textile industry and pharmacological studies 
included in safety tests. 
Figure 7.1
Percentages of animals used in toxicity tests for toxicological
 and other safety evaluation
5,88
10,90
10,11
1,24
22,32
7,55
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vertebrates not included in
other columns
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There is an increase from 32%, 36% to 42% over the last three reports of the proportion of 
animals used for acute and sub-acute tests respectively. This represents in animal numbers an 
increase of 39,000 animals since the last report of 2002. Member States attributed the increase 
in part to several phases in new product development and new legislation for example 
requiring that all generic substances should be tested. 
On the other hand one can observe a steady decrease over the last three reports of the 
proportion of animals used for toxicity tests to reproduction going down from: 15%, 12% to 
10% respectively. 
Another important decrease, from 4,5% to 1,2%, is seen in animals used in toxicity tests for 
aquatic vertebrates. 
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III.9. Results of EU Table 8: Type of toxicity tests carried out for toxicological and other 
safety evaluations of products 
Figure 8.1 represents the percentages of the number of animals used in toxicological testing or 
other safety evaluations in relation to the type of products or purposes. It shows a decrease in 
the proportion of animals used in acute and sub-acute toxicity tests in comparison with other 
tests when moving down in the graph for products used A) for human medicine, dentistry and 
veterinary medicine, B) for agriculture, C) for industry, D) for household purposes, E) for 
cosmetics, F) for additives in food for human consumption and G) for additives in food for 
animal consumption. 
Contrary to acute and sub-acute toxicity one can observe an increase in the proportion of 
animals used for irritation and sensitization tests. While further down the graph amongst the 
four first types of products, a maximum amount of testing takes place for products used in 
cosmetics and toiletries. 
The proportion of animals used in sub-chronic and chronic testing seems to follow the same 
pattern as for irritation and sensitization tests with the highest proportion used for D) 
household products and F) additives in food for human consumption. 
0% 20% 40% 60% 80% 100%
 A) for human medicine, dentistry and for
veterinary medicine   
B) used  in agriculture
C) used in industry
D) used  in the household
E) used as cosmetics or  toiletries
F) additives in food for human consumption
G) additives in food for animal consumption
H) potential  or actual contaminents in the
general environment 
I)  other  toxicological or safety evaluations
Figure 8
Percentages of animals used for toxicity tests for toxicological and 
other safety evaluation by types of products
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The pattern of use of carcinogenicity, mutagenicity and toxicity to reproduction tests is rather 
scattered between the different types of products and more difficult to interpret. 
The proportion of animals used for G) additives in food for animal consumption is governed 
by about 90% by 'other' tests. It would be valuable to break down the term 'other' for future 
reporting. 
